SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-24-006600
Filing Date
2024-02-14
Accepted
2024-02-14 16:01:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 60422
  Complete submission text file 0001493152-24-006600.txt   61851
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Subject) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92247 | Film No.: 24637484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1800 KRAFT DRIVE SUITE 100 BLACKSBURG VA 24060
Business Address
Bassaganya-Riera Josep (Filed by) CIK: 0001843575 (see all company filings)

Type: SC 13G/A